Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Julia Rawlings

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
121
0.610
Why?
Patient Safety
2
2018
349
0.510
Why?
Pharmacy Service, Hospital
1
2018
81
0.500
Why?
Organizational Culture
1
2018
162
0.480
Why?
Remote Consultation
1
2022
66
0.170
Why?
Drug Overdose
1
2022
370
0.130
Why?
Pharmacy
1
2017
33
0.120
Why?
Pharmaceutical Services
1
2017
78
0.120
Why?
Benchmarking
1
2017
189
0.110
Why?
Pharmacists
1
2017
240
0.100
Why?
Opioid-Related Disorders
1
2022
602
0.100
Why?
Colchicine
1
2012
21
0.090
Why?
Gout Suppressants
1
2012
20
0.090
Why?
Gout
1
2012
35
0.090
Why?
Hematologic Diseases
1
2012
66
0.090
Why?
Chemical and Drug Induced Liver Injury
1
2012
139
0.080
Why?
Renal Insufficiency
1
2012
173
0.080
Why?
Delivery of Health Care
1
2017
947
0.080
Why?
Attitude of Health Personnel
1
2018
1196
0.070
Why?
Cross-Sectional Studies
2
2018
5883
0.070
Why?
Surveys and Questionnaires
2
2018
6079
0.070
Why?
Endrin
1
2022
11
0.050
Why?
Sumatriptan
1
1999
6
0.040
Why?
Health Maintenance Organizations
1
1999
105
0.040
Why?
Colorado
2
2022
4579
0.030
Why?
Migraine Disorders
1
1999
112
0.030
Why?
Pain
1
2022
784
0.030
Why?
Pharmacies
1
2017
42
0.030
Why?
Analgesics, Opioid
1
2022
1145
0.030
Why?
Counseling
1
2017
409
0.020
Why?
Practice Patterns, Physicians'
1
2022
1358
0.020
Why?
Humans
5
2022
145305
0.020
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
93
0.020
Why?
Insurance, Health, Reimbursement
1
2012
97
0.020
Why?
Drug Interactions
1
2012
401
0.020
Why?
Communication
1
2017
973
0.020
Why?
Enzyme Inhibitors
1
2012
826
0.020
Why?
United States
2
2022
16051
0.020
Why?
Prevalence
1
2012
2838
0.010
Why?
Case-Control Studies
1
2012
3613
0.010
Why?
Electronic Health Records
1
2012
1177
0.010
Why?
Cohort Studies
1
2012
5982
0.010
Why?
Efficiency
1
1999
104
0.010
Why?
Statistics, Nonparametric
1
1999
427
0.010
Why?
Health Services
1
1999
115
0.010
Why?
Cost of Illness
1
1999
322
0.010
Why?
Young Adult
1
2012
14163
0.010
Why?
Middle Aged
2
2012
36021
0.010
Why?
Patient Satisfaction
1
1999
706
0.010
Why?
Adult
2
2012
40627
0.010
Why?
Aged
1
2012
26001
0.010
Why?
Male
2
2012
72628
0.000
Why?
Female
2
2012
78605
0.000
Why?
Quality of Life
1
1999
3197
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)